Home/Pipeline/PRT-004

PRT-004

Immunology

PreclinicalActive

Key Facts

Indication

Immunology

Phase

Preclinical

Status

Active

Company

About Protai

AI‑driven proteomics platform accelerating discovery of selective oncology and immunology therapeutics.

View full company profile

Therapeutic Areas

Oncology Immunology

Other Immunology Drugs

Drug	Company	Phase	Status
SiRx‑Immunology	SiCare Bio	Discovery	Active
Biosimilars Pipeline (Immunology Focus)	Aurobindo Pharma	Development	Active
ABBV-706	AbbVie	Phase 1	Active